Elder Pharma Group will focus aggressively in building over-the-counter (OTC) and direct-to-consumer (DTC) products segment after selling its domestic formulations business, according to industry sources and analysts who track the group.Although the firm is yet to announce a deal for sale of its main business housed under its flagship listed ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.